维普期刊资源整合服务平台（V6.5）

52篇 您的检索式：作者名="GAAL D"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes : a randomized trial 显示文摘	Heine RJ Van Gaal LF Johns D	2005	Ann Intern Med2005，143，8：	1
2	Exenatide versus in- sulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trail显示文摘	Heine R J Van Gaal LF Johns D	2005	Ann Intern Med2005，143，8：	1
3	Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes显示文摘	Heine R J Van Gaal L F Johns D	2005	Ann Intern Med2005，143，8：	1
4	The antitumour effect of the somatostatin analogue TT-232 depends on the treatment regimen显示文摘	Tejeda M Gaal D CsukaO	2003	Cancer Detect Prey2003，27，2：	1
5	Carrier design: Cyto- toxicity and immunogenicity of synthetic branched polypeptides with poly (L-lysine) backbone显示文摘	HUDECZ F GAAL D KURUCZ I	1992	J Controlled Release1992，19，13：	1
6	Exenatide versus insulin glargine in patients with suboptireally controlled type 2 diabetes: a randomized trial 显示文摘	HEINE R J VAN GAAL L F JOHNS D	2005	Ann Intern Med2005，143，8：	1
7	The antitumor activity of the somatostatin structural derivative (TT-232) on different human tumor xenografts显示文摘	Tejeda M Gaal D Barna K	2003	Anticancer Res2003，23，5：	1
8	Exenatide versus insulin glargine in pa- fients with suboptimally controlled type 2 diabetes: a randomized trial显示文摘	Heine R J van Gaal L F Johns D ct al	2005	Ann Intern Med2005，143，8：	1
9	Exenatide versus insulin glargine in patients with suboptimally controlled type 2diabetes: a randomized trial显示文摘	HEINE RJ van GAAL LF JOHNS D et oi	2005	Ann Intern Med2005，143，8：	1
10	Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial 显示文摘	Heine RJ Van Gaal LF Johns D	2005	Ann Inter Med2005，143，8：	1
11	Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial显示文摘	Heine RJ Van Gaal LF Johns D	2005	Ann Intern Med2005，143，：	1
12	Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial显示文摘	Heine RJ Van Gaal LF Johns D	2005	Ann Intern Meal2005，143，8：	1
13	Exenatide versus insulinglargine in patients with suboptimally controlled type 2 diabetes:A ran-domized trial显示文摘	HEINE R J VAN GAAL L F JOHNS D	2005	Ann Intern Med2005，143，8：	1
14	Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes:a randomized trial显示文摘	Heine R J Van Gaal L F Johns D	2005	Ann Intern Med2005，143，8：	1
15	Exenatide versus insu- lin glargine in patients with suboptimally controlled type 2 dia betes : a randomized trial显示文摘	Heine RJ Van Gaal LF Johns D	2005	Ann Intern Med2005，143，8：	1
16	Exenatide versus insulin gargine in patients with suboptimally controlled type 2 diabetes显示文摘	HENIE R J van GAAL L F JOHN D	2005	Ann Intern Med2005，143，：	1
17	The antitumor effect of the somatostatin analogue TT-232 depends on the treatment regimen 显示文摘	Tejeda M Gaal D Csuka O	2003	Cancer Detect Prev2003，27，：	1
18	Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes:a randomized trial显示文摘	Heine RJ Van Gaal LF Johns D		0，，08：	1
19	Exenatide versus insulin glargine in patients with ~uboptimally controlled type 2 diabetes: a randomized triM显示文摘	Heine R J Van Gaal LF Johns D	2005	Ann Intern Med2005，143，9：	1
20	The effect of regular exercise on development of sarcoma tumor and oxida- tive damage in mice liver显示文摘	SASVARI M TAYLOR A W GAAL D	2011	J Sports Sci Med2011，10，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示